FIELD: medicine and pharmaceuticals.
SUBSTANCE: group of inventions relates to the field of medicine and pharmaceuticals, namely, to a medicinal product that includes a compound (A) represented by the formula:
(the P substituents are defined in the claim), and the compound (B) selected from the group from the group consisting of oseltamivir, zanamivir, peramivir, laninamivir, favipiravir, amantadine, rimantadine, VX-787, MHAA4549A, TCN-032, VIS-410, CR-8020, CR-6261, CT-P27, MEDI-8852, tizoxanide; and also to the use of these medicines and to the method of treatment or prevention of influenza.
EFFECT: invention provides a medicine with a high antiviral effect with minimal side effects.
43 cl, 29 tbl, 27 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF | 2016 |
|
RU2712275C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF | 2017 |
|
RU2727962C1 |
| DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF | 2015 |
|
RU2673944C2 |
| SELECTIVE ESTROGEN RECEPTOR INHIBITORS AND USE THEREOF | 2017 |
|
RU2734501C2 |
| QUINOLINE COMPOUNDS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT WHICH INHIBITS URATE TRANSPORTER | 2016 |
|
RU2715229C2 |
| ANTIVIRAL COMPOUNDS AND THEIR APPLICATION | 2010 |
|
RU2552533C2 |
| CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
| BIVALENT BROMODOMAIN INHIBITORS AND ROUTES OF USE THEREOF | 2016 |
|
RU2742035C2 |
| HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS | 2017 |
|
RU2742115C2 |
| ANTIRETROVIRAL COMPOUNDS AND USE THEREOF | 2010 |
|
RU2571662C2 |
